Anti-inflammatory Drugs Market Size, Share & Trends Analysis Report By Drug Class (Anti-inflammatory Biologics, Non-steroidal Anti-inflammatory Drugs, Corticosteroids, Other Drug Classes), By Application (Autoimmune Diseases, Respiratory Diseases, Inflammatory Bowel Disease, Other Application), By Route of Administration (Oral, Parenteral, Inhalation), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 14, 2026 | Author: Debashree B | Format: | Report Code: SR4975DR | Pages: 150

Market Segmentation

  1. Anti-inflammatory Drugs Market, By Drug Class 2022-2034 (USD MILLION/ Units)
    1. Anti-inflammatory Biologics
    2. Non-steroidal Anti-inflammatory Drugs
    3. Corticosteroids
    4. Other Drug Classes
  2. Anti-inflammatory Drugs Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Autoimmune Diseases
      1. Arthritis
      2. Multiple Sclerosis
      3. Other Diseases
    2. Respiratory Diseases
      1. Chronic Obstructive Pulmonary Diseases
      2. Asthma
      3. Other Diseases
    3. Inflammatory Bowel Disease
    4. Other Application
  3. Anti-inflammatory Drugs Market, By Route of Administration 2022-2034 (USD MILLION/ Units)
    1. Oral
    2. Parenteral
    3. Inhalation
  4. Anti-inflammatory Drugs Market, By Distribution Channel 2022-2034 (USD MILLION/ Units)
    1. Hospital Pharmacies
    2. Drug Stores & Retail Pharmacies
    3. Online Pharmacies
  5. Regional Anti-inflammatory Drugs Market
    1. North America
      1. North America Anti-inflammatory Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti-inflammatory Biologics
        2. Non-steroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Other Drug Classes
      2. North America Anti-inflammatory Drugs Market By Application 2022-2034 (USD MILLION/ Units)
        1. Autoimmune Diseases
          1. Arthritis
          2. Multiple Sclerosis
          3. Other Diseases
        2. Respiratory Diseases
          1. Chronic Obstructive Pulmonary Diseases
          2. Asthma
          3. Other Diseases
        3. Inflammatory Bowel Disease
        4. Other Application
      3. North America Anti-inflammatory Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Inhalation
      4. North America Anti-inflammatory Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      5. U.S. Anti-inflammatory Drugs Market
        1. U.S. Anti-inflammatory Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Anti-inflammatory Biologics
          2. Non-steroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Other Drug Classes
        2. U.S. Anti-inflammatory Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Autoimmune Diseases
            1. Arthritis
            2. Multiple Sclerosis
            3. Other Diseases
          2. Respiratory Diseases
            1. Chronic Obstructive Pulmonary Diseases
            2. Asthma
            3. Other Diseases
          3. Inflammatory Bowel Disease
          4. Other Application
        3. U.S. Anti-inflammatory Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Inhalation
        4. U.S. Anti-inflammatory Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      6. Canada Anti-inflammatory Drugs Market
        1. Canada Anti-inflammatory Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Anti-inflammatory Biologics
          2. Non-steroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Other Drug Classes
        2. Canada Anti-inflammatory Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Autoimmune Diseases
            1. Arthritis
            2. Multiple Sclerosis
            3. Other Diseases
          2. Respiratory Diseases
            1. Chronic Obstructive Pulmonary Diseases
            2. Asthma
            3. Other Diseases
          3. Inflammatory Bowel Disease
          4. Other Application
        3. Canada Anti-inflammatory Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Inhalation
        4. Canada Anti-inflammatory Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
    2. Europe
      1. Europe Anti-inflammatory Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti-inflammatory Biologics
        2. Non-steroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Other Drug Classes
      2. Europe Anti-inflammatory Drugs Market By Application 2022-2034 (USD MILLION/ Units)
        1. Autoimmune Diseases
          1. Arthritis
          2. Multiple Sclerosis
          3. Other Diseases
        2. Respiratory Diseases
          1. Chronic Obstructive Pulmonary Diseases
          2. Asthma
          3. Other Diseases
        3. Inflammatory Bowel Disease
        4. Other Application
      3. Europe Anti-inflammatory Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Inhalation
      4. Europe Anti-inflammatory Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      5. U.K. Anti-inflammatory Drugs Market
        1. U.K. Anti-inflammatory Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Anti-inflammatory Biologics
          2. Non-steroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Other Drug Classes
        2. U.K. Anti-inflammatory Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Autoimmune Diseases
            1. Arthritis
            2. Multiple Sclerosis
            3. Other Diseases
          2. Respiratory Diseases
            1. Chronic Obstructive Pulmonary Diseases
            2. Asthma
            3. Other Diseases
          3. Inflammatory Bowel Disease
          4. Other Application
        3. U.K. Anti-inflammatory Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Inhalation
        4. U.K. Anti-inflammatory Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      6. Germany Anti-inflammatory Drugs Market
        1. Germany Anti-inflammatory Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Anti-inflammatory Biologics
          2. Non-steroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Other Drug Classes
        2. Germany Anti-inflammatory Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Autoimmune Diseases
            1. Arthritis
            2. Multiple Sclerosis
            3. Other Diseases
          2. Respiratory Diseases
            1. Chronic Obstructive Pulmonary Diseases
            2. Asthma
            3. Other Diseases
          3. Inflammatory Bowel Disease
          4. Other Application
        3. Germany Anti-inflammatory Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Inhalation
        4. Germany Anti-inflammatory Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      7. France Anti-inflammatory Drugs Market
        1. France Anti-inflammatory Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Anti-inflammatory Biologics
          2. Non-steroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Other Drug Classes
        2. France Anti-inflammatory Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Autoimmune Diseases
            1. Arthritis
            2. Multiple Sclerosis
            3. Other Diseases
          2. Respiratory Diseases
            1. Chronic Obstructive Pulmonary Diseases
            2. Asthma
            3. Other Diseases
          3. Inflammatory Bowel Disease
          4. Other Application
        3. France Anti-inflammatory Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Inhalation
        4. France Anti-inflammatory Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      8. Spain Anti-inflammatory Drugs Market
        1. Spain Anti-inflammatory Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Anti-inflammatory Biologics
          2. Non-steroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Other Drug Classes
        2. Spain Anti-inflammatory Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Autoimmune Diseases
            1. Arthritis
            2. Multiple Sclerosis
            3. Other Diseases
          2. Respiratory Diseases
            1. Chronic Obstructive Pulmonary Diseases
            2. Asthma
            3. Other Diseases
          3. Inflammatory Bowel Disease
          4. Other Application
        3. Spain Anti-inflammatory Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Inhalation
        4. Spain Anti-inflammatory Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      9. Italy Anti-inflammatory Drugs Market
        1. Italy Anti-inflammatory Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Anti-inflammatory Biologics
          2. Non-steroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Other Drug Classes
        2. Italy Anti-inflammatory Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Autoimmune Diseases
            1. Arthritis
            2. Multiple Sclerosis
            3. Other Diseases
          2. Respiratory Diseases
            1. Chronic Obstructive Pulmonary Diseases
            2. Asthma
            3. Other Diseases
          3. Inflammatory Bowel Disease
          4. Other Application
        3. Italy Anti-inflammatory Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Inhalation
        4. Italy Anti-inflammatory Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      10. Russia Anti-inflammatory Drugs Market
        1. Russia Anti-inflammatory Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Anti-inflammatory Biologics
          2. Non-steroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Other Drug Classes
        2. Russia Anti-inflammatory Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Autoimmune Diseases
            1. Arthritis
            2. Multiple Sclerosis
            3. Other Diseases
          2. Respiratory Diseases
            1. Chronic Obstructive Pulmonary Diseases
            2. Asthma
            3. Other Diseases
          3. Inflammatory Bowel Disease
          4. Other Application
        3. Russia Anti-inflammatory Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Inhalation
        4. Russia Anti-inflammatory Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      11. Nordic Anti-inflammatory Drugs Market
        1. Nordic Anti-inflammatory Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Anti-inflammatory Biologics
          2. Non-steroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Other Drug Classes
        2. Nordic Anti-inflammatory Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Autoimmune Diseases
            1. Arthritis
            2. Multiple Sclerosis
            3. Other Diseases
          2. Respiratory Diseases
            1. Chronic Obstructive Pulmonary Diseases
            2. Asthma
            3. Other Diseases
          3. Inflammatory Bowel Disease
          4. Other Application
        3. Nordic Anti-inflammatory Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Inhalation
        4. Nordic Anti-inflammatory Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      12. Benelux Anti-inflammatory Drugs Market
        1. Benelux Anti-inflammatory Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Anti-inflammatory Biologics
          2. Non-steroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Other Drug Classes
        2. Benelux Anti-inflammatory Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Autoimmune Diseases
            1. Arthritis
            2. Multiple Sclerosis
            3. Other Diseases
          2. Respiratory Diseases
            1. Chronic Obstructive Pulmonary Diseases
            2. Asthma
            3. Other Diseases
          3. Inflammatory Bowel Disease
          4. Other Application
        3. Benelux Anti-inflammatory Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Inhalation
        4. Benelux Anti-inflammatory Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      13. Rest of Europe Anti-inflammatory Drugs Market
        1. Rest of Europe Anti-inflammatory Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Anti-inflammatory Biologics
          2. Non-steroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Other Drug Classes
        2. Rest of Europe Anti-inflammatory Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Autoimmune Diseases
            1. Arthritis
            2. Multiple Sclerosis
            3. Other Diseases
          2. Respiratory Diseases
            1. Chronic Obstructive Pulmonary Diseases
            2. Asthma
            3. Other Diseases
          3. Inflammatory Bowel Disease
          4. Other Application
        3. Rest of Europe Anti-inflammatory Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Inhalation
        4. Rest of Europe Anti-inflammatory Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
    3. APAC
      1. APAC Anti-inflammatory Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti-inflammatory Biologics
        2. Non-steroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Other Drug Classes
      2. APAC Anti-inflammatory Drugs Market By Application 2022-2034 (USD MILLION/ Units)
        1. Autoimmune Diseases
          1. Arthritis
          2. Multiple Sclerosis
          3. Other Diseases
        2. Respiratory Diseases
          1. Chronic Obstructive Pulmonary Diseases
          2. Asthma
          3. Other Diseases
        3. Inflammatory Bowel Disease
        4. Other Application
      3. APAC Anti-inflammatory Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Inhalation
      4. APAC Anti-inflammatory Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      5. China Anti-inflammatory Drugs Market
        1. China Anti-inflammatory Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Anti-inflammatory Biologics
          2. Non-steroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Other Drug Classes
        2. China Anti-inflammatory Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Autoimmune Diseases
            1. Arthritis
            2. Multiple Sclerosis
            3. Other Diseases
          2. Respiratory Diseases
            1. Chronic Obstructive Pulmonary Diseases
            2. Asthma
            3. Other Diseases
          3. Inflammatory Bowel Disease
          4. Other Application
        3. China Anti-inflammatory Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Inhalation
        4. China Anti-inflammatory Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      6. Korea Anti-inflammatory Drugs Market
        1. Korea Anti-inflammatory Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Anti-inflammatory Biologics
          2. Non-steroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Other Drug Classes
        2. Korea Anti-inflammatory Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Autoimmune Diseases
            1. Arthritis
            2. Multiple Sclerosis
            3. Other Diseases
          2. Respiratory Diseases
            1. Chronic Obstructive Pulmonary Diseases
            2. Asthma
            3. Other Diseases
          3. Inflammatory Bowel Disease
          4. Other Application
        3. Korea Anti-inflammatory Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Inhalation
        4. Korea Anti-inflammatory Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      7. Japan Anti-inflammatory Drugs Market
        1. Japan Anti-inflammatory Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Anti-inflammatory Biologics
          2. Non-steroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Other Drug Classes
        2. Japan Anti-inflammatory Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Autoimmune Diseases
            1. Arthritis
            2. Multiple Sclerosis
            3. Other Diseases
          2. Respiratory Diseases
            1. Chronic Obstructive Pulmonary Diseases
            2. Asthma
            3. Other Diseases
          3. Inflammatory Bowel Disease
          4. Other Application
        3. Japan Anti-inflammatory Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Inhalation
        4. Japan Anti-inflammatory Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      8. India Anti-inflammatory Drugs Market
        1. India Anti-inflammatory Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Anti-inflammatory Biologics
          2. Non-steroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Other Drug Classes
        2. India Anti-inflammatory Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Autoimmune Diseases
            1. Arthritis
            2. Multiple Sclerosis
            3. Other Diseases
          2. Respiratory Diseases
            1. Chronic Obstructive Pulmonary Diseases
            2. Asthma
            3. Other Diseases
          3. Inflammatory Bowel Disease
          4. Other Application
        3. India Anti-inflammatory Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Inhalation
        4. India Anti-inflammatory Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      9. Australia Anti-inflammatory Drugs Market
        1. Australia Anti-inflammatory Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Anti-inflammatory Biologics
          2. Non-steroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Other Drug Classes
        2. Australia Anti-inflammatory Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Autoimmune Diseases
            1. Arthritis
            2. Multiple Sclerosis
            3. Other Diseases
          2. Respiratory Diseases
            1. Chronic Obstructive Pulmonary Diseases
            2. Asthma
            3. Other Diseases
          3. Inflammatory Bowel Disease
          4. Other Application
        3. Australia Anti-inflammatory Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Inhalation
        4. Australia Anti-inflammatory Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      10. Singapore Anti-inflammatory Drugs Market
        1. Singapore Anti-inflammatory Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Anti-inflammatory Biologics
          2. Non-steroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Other Drug Classes
        2. Singapore Anti-inflammatory Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Autoimmune Diseases
            1. Arthritis
            2. Multiple Sclerosis
            3. Other Diseases
          2. Respiratory Diseases
            1. Chronic Obstructive Pulmonary Diseases
            2. Asthma
            3. Other Diseases
          3. Inflammatory Bowel Disease
          4. Other Application
        3. Singapore Anti-inflammatory Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Inhalation
        4. Singapore Anti-inflammatory Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      11. Taiwan Anti-inflammatory Drugs Market
        1. Taiwan Anti-inflammatory Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Anti-inflammatory Biologics
          2. Non-steroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Other Drug Classes
        2. Taiwan Anti-inflammatory Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Autoimmune Diseases
            1. Arthritis
            2. Multiple Sclerosis
            3. Other Diseases
          2. Respiratory Diseases
            1. Chronic Obstructive Pulmonary Diseases
            2. Asthma
            3. Other Diseases
          3. Inflammatory Bowel Disease
          4. Other Application
        3. Taiwan Anti-inflammatory Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Inhalation
        4. Taiwan Anti-inflammatory Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      12. South East Asia Anti-inflammatory Drugs Market
        1. South East Asia Anti-inflammatory Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Anti-inflammatory Biologics
          2. Non-steroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Other Drug Classes
        2. South East Asia Anti-inflammatory Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Autoimmune Diseases
            1. Arthritis
            2. Multiple Sclerosis
            3. Other Diseases
          2. Respiratory Diseases
            1. Chronic Obstructive Pulmonary Diseases
            2. Asthma
            3. Other Diseases
          3. Inflammatory Bowel Disease
          4. Other Application
        3. South East Asia Anti-inflammatory Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Inhalation
        4. South East Asia Anti-inflammatory Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      13. Rest of Asia-Pacific Anti-inflammatory Drugs Market
        1. Rest of Asia-Pacific Anti-inflammatory Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Anti-inflammatory Biologics
          2. Non-steroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Other Drug Classes
        2. Rest of Asia-Pacific Anti-inflammatory Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Autoimmune Diseases
            1. Arthritis
            2. Multiple Sclerosis
            3. Other Diseases
          2. Respiratory Diseases
            1. Chronic Obstructive Pulmonary Diseases
            2. Asthma
            3. Other Diseases
          3. Inflammatory Bowel Disease
          4. Other Application
        3. Rest of Asia-Pacific Anti-inflammatory Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Inhalation
        4. Rest of Asia-Pacific Anti-inflammatory Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
    4. Middle East and Africa
      1. Middle East and Africa Anti-inflammatory Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti-inflammatory Biologics
        2. Non-steroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Other Drug Classes
      2. Middle East and Africa Anti-inflammatory Drugs Market By Application 2022-2034 (USD MILLION/ Units)
        1. Autoimmune Diseases
          1. Arthritis
          2. Multiple Sclerosis
          3. Other Diseases
        2. Respiratory Diseases
          1. Chronic Obstructive Pulmonary Diseases
          2. Asthma
          3. Other Diseases
        3. Inflammatory Bowel Disease
        4. Other Application
      3. Middle East and Africa Anti-inflammatory Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Inhalation
      4. Middle East and Africa Anti-inflammatory Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      5. UAE Anti-inflammatory Drugs Market
        1. UAE Anti-inflammatory Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Anti-inflammatory Biologics
          2. Non-steroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Other Drug Classes
        2. UAE Anti-inflammatory Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Autoimmune Diseases
            1. Arthritis
            2. Multiple Sclerosis
            3. Other Diseases
          2. Respiratory Diseases
            1. Chronic Obstructive Pulmonary Diseases
            2. Asthma
            3. Other Diseases
          3. Inflammatory Bowel Disease
          4. Other Application
        3. UAE Anti-inflammatory Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Inhalation
        4. UAE Anti-inflammatory Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      6. Turkey Anti-inflammatory Drugs Market
        1. Turkey Anti-inflammatory Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Anti-inflammatory Biologics
          2. Non-steroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Other Drug Classes
        2. Turkey Anti-inflammatory Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Autoimmune Diseases
            1. Arthritis
            2. Multiple Sclerosis
            3. Other Diseases
          2. Respiratory Diseases
            1. Chronic Obstructive Pulmonary Diseases
            2. Asthma
            3. Other Diseases
          3. Inflammatory Bowel Disease
          4. Other Application
        3. Turkey Anti-inflammatory Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Inhalation
        4. Turkey Anti-inflammatory Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      7. Saudi Arabia Anti-inflammatory Drugs Market
        1. Saudi Arabia Anti-inflammatory Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Anti-inflammatory Biologics
          2. Non-steroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Other Drug Classes
        2. Saudi Arabia Anti-inflammatory Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Autoimmune Diseases
            1. Arthritis
            2. Multiple Sclerosis
            3. Other Diseases
          2. Respiratory Diseases
            1. Chronic Obstructive Pulmonary Diseases
            2. Asthma
            3. Other Diseases
          3. Inflammatory Bowel Disease
          4. Other Application
        3. Saudi Arabia Anti-inflammatory Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Inhalation
        4. Saudi Arabia Anti-inflammatory Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      8. South Africa Anti-inflammatory Drugs Market
        1. South Africa Anti-inflammatory Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Anti-inflammatory Biologics
          2. Non-steroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Other Drug Classes
        2. South Africa Anti-inflammatory Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Autoimmune Diseases
            1. Arthritis
            2. Multiple Sclerosis
            3. Other Diseases
          2. Respiratory Diseases
            1. Chronic Obstructive Pulmonary Diseases
            2. Asthma
            3. Other Diseases
          3. Inflammatory Bowel Disease
          4. Other Application
        3. South Africa Anti-inflammatory Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Inhalation
        4. South Africa Anti-inflammatory Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      9. Egypt Anti-inflammatory Drugs Market
        1. Egypt Anti-inflammatory Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Anti-inflammatory Biologics
          2. Non-steroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Other Drug Classes
        2. Egypt Anti-inflammatory Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Autoimmune Diseases
            1. Arthritis
            2. Multiple Sclerosis
            3. Other Diseases
          2. Respiratory Diseases
            1. Chronic Obstructive Pulmonary Diseases
            2. Asthma
            3. Other Diseases
          3. Inflammatory Bowel Disease
          4. Other Application
        3. Egypt Anti-inflammatory Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Inhalation
        4. Egypt Anti-inflammatory Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      10. Nigeria Anti-inflammatory Drugs Market
        1. Nigeria Anti-inflammatory Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Anti-inflammatory Biologics
          2. Non-steroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Other Drug Classes
        2. Nigeria Anti-inflammatory Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Autoimmune Diseases
            1. Arthritis
            2. Multiple Sclerosis
            3. Other Diseases
          2. Respiratory Diseases
            1. Chronic Obstructive Pulmonary Diseases
            2. Asthma
            3. Other Diseases
          3. Inflammatory Bowel Disease
          4. Other Application
        3. Nigeria Anti-inflammatory Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Inhalation
        4. Nigeria Anti-inflammatory Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      11. Rest of MEA Anti-inflammatory Drugs Market
        1. Rest of MEA Anti-inflammatory Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Anti-inflammatory Biologics
          2. Non-steroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Other Drug Classes
        2. Rest of MEA Anti-inflammatory Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Autoimmune Diseases
            1. Arthritis
            2. Multiple Sclerosis
            3. Other Diseases
          2. Respiratory Diseases
            1. Chronic Obstructive Pulmonary Diseases
            2. Asthma
            3. Other Diseases
          3. Inflammatory Bowel Disease
          4. Other Application
        3. Rest of MEA Anti-inflammatory Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Inhalation
        4. Rest of MEA Anti-inflammatory Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
    5. LATAM
      1. LATAM Anti-inflammatory Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti-inflammatory Biologics
        2. Non-steroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Other Drug Classes
      2. LATAM Anti-inflammatory Drugs Market By Application 2022-2034 (USD MILLION/ Units)
        1. Autoimmune Diseases
          1. Arthritis
          2. Multiple Sclerosis
          3. Other Diseases
        2. Respiratory Diseases
          1. Chronic Obstructive Pulmonary Diseases
          2. Asthma
          3. Other Diseases
        3. Inflammatory Bowel Disease
        4. Other Application
      3. LATAM Anti-inflammatory Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Inhalation
      4. LATAM Anti-inflammatory Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      5. Brazil Anti-inflammatory Drugs Market
        1. Brazil Anti-inflammatory Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Anti-inflammatory Biologics
          2. Non-steroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Other Drug Classes
        2. Brazil Anti-inflammatory Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Autoimmune Diseases
            1. Arthritis
            2. Multiple Sclerosis
            3. Other Diseases
          2. Respiratory Diseases
            1. Chronic Obstructive Pulmonary Diseases
            2. Asthma
            3. Other Diseases
          3. Inflammatory Bowel Disease
          4. Other Application
        3. Brazil Anti-inflammatory Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Inhalation
        4. Brazil Anti-inflammatory Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      6. Mexico Anti-inflammatory Drugs Market
        1. Mexico Anti-inflammatory Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Anti-inflammatory Biologics
          2. Non-steroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Other Drug Classes
        2. Mexico Anti-inflammatory Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Autoimmune Diseases
            1. Arthritis
            2. Multiple Sclerosis
            3. Other Diseases
          2. Respiratory Diseases
            1. Chronic Obstructive Pulmonary Diseases
            2. Asthma
            3. Other Diseases
          3. Inflammatory Bowel Disease
          4. Other Application
        3. Mexico Anti-inflammatory Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Inhalation
        4. Mexico Anti-inflammatory Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      7. Argentina Anti-inflammatory Drugs Market
        1. Argentina Anti-inflammatory Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Anti-inflammatory Biologics
          2. Non-steroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Other Drug Classes
        2. Argentina Anti-inflammatory Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Autoimmune Diseases
            1. Arthritis
            2. Multiple Sclerosis
            3. Other Diseases
          2. Respiratory Diseases
            1. Chronic Obstructive Pulmonary Diseases
            2. Asthma
            3. Other Diseases
          3. Inflammatory Bowel Disease
          4. Other Application
        3. Argentina Anti-inflammatory Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Inhalation
        4. Argentina Anti-inflammatory Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      8. Chile Anti-inflammatory Drugs Market
        1. Chile Anti-inflammatory Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Anti-inflammatory Biologics
          2. Non-steroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Other Drug Classes
        2. Chile Anti-inflammatory Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Autoimmune Diseases
            1. Arthritis
            2. Multiple Sclerosis
            3. Other Diseases
          2. Respiratory Diseases
            1. Chronic Obstructive Pulmonary Diseases
            2. Asthma
            3. Other Diseases
          3. Inflammatory Bowel Disease
          4. Other Application
        3. Chile Anti-inflammatory Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Inhalation
        4. Chile Anti-inflammatory Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      9. Colombia Anti-inflammatory Drugs Market
        1. Colombia Anti-inflammatory Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Anti-inflammatory Biologics
          2. Non-steroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Other Drug Classes
        2. Colombia Anti-inflammatory Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Autoimmune Diseases
            1. Arthritis
            2. Multiple Sclerosis
            3. Other Diseases
          2. Respiratory Diseases
            1. Chronic Obstructive Pulmonary Diseases
            2. Asthma
            3. Other Diseases
          3. Inflammatory Bowel Disease
          4. Other Application
        3. Colombia Anti-inflammatory Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Inhalation
        4. Colombia Anti-inflammatory Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      10. Rest of LATAM Anti-inflammatory Drugs Market
        1. Rest of LATAM Anti-inflammatory Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Anti-inflammatory Biologics
          2. Non-steroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Other Drug Classes
        2. Rest of LATAM Anti-inflammatory Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Autoimmune Diseases
            1. Arthritis
            2. Multiple Sclerosis
            3. Other Diseases
          2. Respiratory Diseases
            1. Chronic Obstructive Pulmonary Diseases
            2. Asthma
            3. Other Diseases
          3. Inflammatory Bowel Disease
          4. Other Application
        3. Rest of LATAM Anti-inflammatory Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Inhalation
        4. Rest of LATAM Anti-inflammatory Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on: